GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...
The sensor attaches to the top of the Ellipta inhaler and automatically records when patients use their device. The data it gathers is then sent to a smartphone app for both the user and their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback